IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Cambrex Records Rise in Profits and Sales

12:10 AM MDT | May 6, 2011 | Deepti Ramesh

Cambrex (East Rutherford, NJ) reported a 61% increase in net profits fro the first quarter ended March 31, 2011, to $2.7 million, compared with the year-ago period, on net sales up 10%, to $61.3 million. The rise in sales is primarily due to higher sales of an active pharmaceutical ingredient (API) to a customer who resolved their supply chain disruption which had reduced Cambrex's sales volumes in the first quarter of 2010; higher volumes of generic APIs; and increased volumes for a recently approved product, Cambrex says. These increases were partially offset...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa